Lilian Stern Principalread more
Lilian Stern has been a senior investor relations counselor in the biotechnology industry for over 20 years, representing more than 300 companies ranging from start-ups to large-cap public companies, in a broad range of development stages and therapeutic areas. As Principal of Stern IR, she works closely with all client teams, providing skilled and knowledgeable IR counsel. Lilian previously worked as a biotechnology sell-side analyst at Donaldson, Lufkin & Jenrette/Credit Suisse First Boston and was also Vice President of Biotechnology at AgriCapital Corporation. She holds an A.B. in Molecular Biology with distinction from Cornell University and a J.D. with honors from Harvard Law School.
Lilian is a member of National Investor Relations Institute (NIRI) as well as the New York Biotechnology Association (NYBA). Lilian established the Stern IR Foundation in 2008 to make contributions and otherwise support charities related to autism and other human health issues, as well as organizations that support cultural, educational and religious institutions. She sits on the board of Springboard Enterprises, the premier platform where entrepreneurs, investors, and industry experts meet to build great women-led businesses. Lilian is an avid reader and philanthropist and lives on the Upper West Side of New York with her family.
Fun fact: Lilian's father wrote a biography of the psychologist C.G. Jung and she finds the occasion to apply his theory of archetypes to the biotechnology industry!

















